摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[4-(methylsulfonyl)benzyl]-4-[3-oxo-3-{3-(tert-butyldimethylsilyloxy)phenyl}propyl]homopiperazine | 199938-51-7

中文名称
——
中文别名
——
英文名称
1-[4-(methylsulfonyl)benzyl]-4-[3-oxo-3-{3-(tert-butyldimethylsilyloxy)phenyl}propyl]homopiperazine
英文别名
1-[3-[Tert-butyl(dimethyl)silyl]oxyphenyl]-3-[4-[(4-methylsulfonylphenyl)methyl]-1,4-diazepan-1-yl]propan-1-one
1-[4-(methylsulfonyl)benzyl]-4-[3-oxo-3-{3-(tert-butyldimethylsilyloxy)phenyl}propyl]homopiperazine化学式
CAS
199938-51-7
化学式
C28H42N2O4SSi
mdl
——
分子量
530.804
InChiKey
XQWKAGSBDLYECE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.25
  • 重原子数:
    36
  • 可旋转键数:
    10
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    75.3
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-[4-(methylsulfonyl)benzyl]-4-[3-oxo-3-{3-(tert-butyldimethylsilyloxy)phenyl}propyl]homopiperazine四丁基氟化铵 作用下, 以 四氢呋喃 为溶剂, 生成 3-{1-(4-Chloro-phenyl)-1-hydroxy-3-[4-(4-methanesulfonyl-benzyl)-[1,4]diazepan-1-yl]-propyl}-phenol
    参考文献:
    名称:
    Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives
    摘要:
    N',N'-Disubstituted homopiperazine derivatives have been discovered as CC-chemokine receptor 2b (CCR2b) inhibitors with submicromolar activity in the CCR2b binding assay. A 4-substituted benzyl group on one homopiperazine nitroger was an important moiety for binding affinity to the CCR2b receptor. The SAR for CCR2b binding affinity correlated inversely with the a factor of the functional group on this benzyl moiety. Introduction of hydroxy groups to appropriate positions in the 3,3-diphenylpropyl group on the other homopiperazine nitrogen increased CCR2b binding activity. The synthesis of an informer library to search for alternative substructures is also described. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2004.08.008
  • 作为产物:
    参考文献:
    名称:
    Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives
    摘要:
    N',N'-Disubstituted homopiperazine derivatives have been discovered as CC-chemokine receptor 2b (CCR2b) inhibitors with submicromolar activity in the CCR2b binding assay. A 4-substituted benzyl group on one homopiperazine nitroger was an important moiety for binding affinity to the CCR2b receptor. The SAR for CCR2b binding affinity correlated inversely with the a factor of the functional group on this benzyl moiety. Introduction of hydroxy groups to appropriate positions in the 3,3-diphenylpropyl group on the other homopiperazine nitrogen increased CCR2b binding activity. The synthesis of an informer library to search for alternative substructures is also described. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2004.08.008
点击查看最新优质反应信息

文献信息

  • Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
    申请人:Teijin Intellectual Property Center Limited
    公开号:US06686353B1
    公开(公告)日:2004-02-03
    Cyclic diamines of formula (I) or their pharmacologically acceptable acid addition salts, and their medical applications are described. These compounds inhibit the action of chemokines such as MIP-1a and/or MCP-1 on target cells, and are useful as a therapeutic drug and/or preventative drug in diseases, such as atherosclerosis, rheumatoid arthritis, and the like where blood monocytes and lymphocytes infiltrate into tissue.
    本文描述了式(I)的环状二胺或其药理学上可接受的酸盐以及它们的医学应用。这些化合物抑制趋化因子如MIP-1a和/或MCP-1对靶细胞的作用,可用作治疗药物和/或预防药物,用于动脉粥样硬化、类风湿性关节炎等疾病,在这些疾病中,血液单核细胞和淋巴细胞浸润组织。
  • Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives
    作者:Minoru Imai、Tatsuki Shiota、Ken-ichiro Kataoka、Christine M. Tarby、Wilna J. Moree、Takaharu Tsutsumi、Masaki Sudo、Michele M. Ramirez-Weinhouse、Daniel Comer、Chung-Ming Sun、Shinsuke Yamagami、Hiroko Tanaka、Takuya Morita、Takahiko Hada、Jonathan Greene、Doug Barnum、John Saunders、Peter L. Myers、Yoshinori Kato、Noriaki Endo
    DOI:10.1016/j.bmcl.2004.08.008
    日期:2004.11
    N',N'-Disubstituted homopiperazine derivatives have been discovered as CC-chemokine receptor 2b (CCR2b) inhibitors with submicromolar activity in the CCR2b binding assay. A 4-substituted benzyl group on one homopiperazine nitroger was an important moiety for binding affinity to the CCR2b receptor. The SAR for CCR2b binding affinity correlated inversely with the a factor of the functional group on this benzyl moiety. Introduction of hydroxy groups to appropriate positions in the 3,3-diphenylpropyl group on the other homopiperazine nitrogen increased CCR2b binding activity. The synthesis of an informer library to search for alternative substructures is also described. (C) 2004 Elsevier Ltd. All rights reserved.
查看更多